EZH2 Inhibitor Improves Cognitive Behavior in CAA

被引:0
|
作者
Iqbal, Zahid
El Hamamy, Ahmad
Ngoc Mai Le
Ranjan, Arya
Qi, Li
Tan, Chunfeng
McCullough, Louise D.
Li, Jun
机构
关键词
D O I
10.1161/str.55.suppl_1.WMP114
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
WMP114
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The Role of EZH2 Inhibitor, GSK-126, in Seizure Susceptibility
    Zhongcheng Wang
    Yaxin Su
    Dezheng Zhuang
    Ting Lan
    Journal of Molecular Neuroscience, 2021, 71 : 556 - 564
  • [22] Epigenetic Targeting with EZH2 and HDAC Inhibitors Is Synergistic in EZH2 Deregulated Lymphomas
    Lue, Jennifer Kimberly
    Prabhu, Sathyen A.
    Liu, Yuxuan
    O'Connor, Owen A.
    Amengual, Jennifer E.
    BLOOD, 2016, 128 (22)
  • [23] THE ROLE OF EZH2 IN MEDULLOBLASTOMA
    Sola, Ismail
    Venktaraman, Sujatha
    Balakrishnan, Ilongo
    Birks, Diane
    Foreman, Nicholas
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2016, 18 : 113 - 113
  • [24] Targeting EZH2 in cancer
    Kimberly H Kim
    Charles W M Roberts
    Nature Medicine, 2016, 22 : 128 - 134
  • [25] Targeting EZH2 with tazemetostat
    Makita, Shinichi
    Tobinai, Kensei
    LANCET ONCOLOGY, 2018, 19 (05): : 586 - 587
  • [26] EZH2 Goes Solo
    Cavalli, Giacomo
    SCIENCE, 2012, 338 (6113) : 1430 - 1431
  • [27] EZH2: a pleiotropic protein
    Burmeister, Thomas
    BLOOD, 2016, 128 (07) : 888 - 889
  • [28] EZH2与癌症
    唐博瑞
    宋檀婧
    孙立栋
    华中科技大学学报(医学版), 2022, 51 (03) : 415 - 419
  • [29] Inhibition of methyltransferase EZH2
    Dhanak, Dashyant
    CANCER RESEARCH, 2012, 72
  • [30] Aberrations of EZH2 in Cancer
    Chase, Andrew
    Cross, Nicholas C. P.
    CLINICAL CANCER RESEARCH, 2011, 17 (09) : 2613 - 2618